XGN vs. LFVN
XGN (Exagen Inc.) and LFVN (LifeVantage Corporation) are both stocks. XGN operates in Diagnostics & Research (Healthcare), while LFVN operates in Packaged Foods (Consumer Defensive). Over the past 5 years, XGN returned -22.83%/yr vs 0.44%/yr for LFVN. At a 0.12 correlation, their price movements are largely independent.
Performance
XGN vs. LFVN - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, XGN achieves a -27.30% return, which is significantly lower than LFVN's 0.30% return.
XGN
- 1D
- -2.64%
- 1M
- 3.76%
- YTD
- -27.30%
- 6M
- -33.33%
- 1Y
- -38.87%
- 3Y*
- 12.43%
- 5Y*
- -22.83%
- 10Y*
- —
LFVN
- 1D
- -5.15%
- 1M
- 9.07%
- YTD
- 0.30%
- 6M
- 3.15%
- 1Y
- -50.18%
- 3Y*
- 14.68%
- 5Y*
- 0.44%
- 10Y*
- -6.08%
XGN vs. LFVN - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | |
|---|---|---|---|---|---|---|---|---|
XGN Exagen Inc. | -27.30% | 48.29% | 106.03% | -17.08% | -79.36% | -11.89% | -48.03% | 51.19% |
LFVN LifeVantage Corporation | 0.30% | -64.29% | 197.21% | 74.03% | -39.78% | -32.19% | -40.29% | 17.72% |
Correlation
The correlation between XGN and LFVN is 0.16, which is low. Their price movements are largely independent, making them effective diversification partners.
| Correlation | |
|---|---|
Correlation (1Y) Calculated over the trailing 1-year period | 0.16 |
Correlation (3Y) Calculated over the trailing 3-year period | 0.05 |
Correlation (5Y) Calculated over the trailing 5-year period | 0.07 |
Correlation (All Time) Calculated using the full available price history since Sep 19, 2019 | 0.12 |
The correlation between XGN and LFVN shifts across timeframes, from 0.05 (3 years) to 0.16 (1 year), reflecting how their relationship changes across market environments.
Fundamentals
XGN:
$105.44M
LFVN:
$76.97M
XGN:
-$0.90
LFVN:
$0.45
XGN:
1.45
LFVN:
0.40
XGN:
7.31
LFVN:
2.31
XGN:
$68.38M
LFVN:
$195.32M
XGN:
$39.88M
LFVN:
$152.62M
XGN:
-$15.91M
LFVN:
$8.69M
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
XGN vs. LFVN — Risk / Return Rank
XGN
LFVN
XGN vs. LFVN - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for Exagen Inc. (XGN) and LifeVantage Corporation (LFVN). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.
| XGN | LFVN | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | +0.09 | ||
| Sortino ratioReturn per unit of downside risk | +0.11 | ||
| Omega ratioGain probability vs. loss probability | 0.93 | 0.91 | +0.02 |
| Calmar ratioReturn relative to maximum drawdown | -0.50 | -0.70 | +0.20 |
| Martin ratioReturn relative to average drawdown | -0.79 | -1.02 | +0.23 |
Loading charts...
Drawdowns
XGN vs. LFVN - Drawdown Comparison
The maximum XGN drawdown since its inception was -95.22%, roughly equal to the maximum LFVN drawdown of -99.57%. Use the drawdown chart below to compare losses from any high point for XGN and LFVN.
Loading charts...
Drawdown Indicators
| XGN | LFVN | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -95.22% | -99.57% | +4.35% |
Max Drawdown (1Y)Largest decline over 1 year | -77.84% | -71.73% | -6.11% |
Max Drawdown (3Y)Largest decline over 3 years | -77.84% | -83.90% | +6.06% |
Max Drawdown (5Y)Largest decline over 5 years | -91.50% | -83.90% | -7.60% |
Max Drawdown (10Y)Largest decline over 10 years | — | -83.90% | — |
Current DrawdownCurrent decline from peak | -84.48% | -93.76% | +9.28% |
Average DrawdownAverage peak-to-trough decline | -70.88% | -89.57% | +18.69% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 49.25% | 49.29% | -0.04% |
Volatility
XGN vs. LFVN - Volatility Comparison
The current volatility for Exagen Inc. (XGN) is 28.54%, while LifeVantage Corporation (LFVN) has a volatility of 52.98%. This indicates that XGN experiences smaller price fluctuations and is considered to be less risky than LFVN based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| XGN | LFVN | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 28.54% | 52.98% | -24.44% |
Volatility (6M)Calculated over the trailing 6-month period | 59.22% | 68.93% | -9.71% |
Volatility (1Y)Calculated over the trailing 1-year period | 70.16% | 77.68% | -7.52% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 83.17% | 66.40% | +16.77% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 88.52% | 62.17% | +26.35% |
Dividends
XGN vs. LFVN - Dividend Comparison
XGN has not paid dividends to shareholders, while LFVN's dividend yield for the trailing twelve months is around 3.04%.
| Position | TTM | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
LFVN LifeVantage Corporation | 3.04% | 2.84% | 0.88% | 8.33% | 2.42% |
XGN Exagen Inc. | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Financials
XGN vs. LFVN - Financials Comparison
This section allows you to compare key financial metrics between Exagen Inc. and LifeVantage Corporation. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities
XGN vs. LFVN - Profitability Comparison
XGN - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, Exagen Inc. reported a gross profit of 10.21M and revenue of 17.31M. Therefore, the gross margin over that period was 59.0%.
LFVN - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, LifeVantage Corporation reported a gross profit of 34.54M and revenue of 43.72M. Therefore, the gross margin over that period was 79.0%.
XGN - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, Exagen Inc. reported an operating income of -3.41M and revenue of 17.31M, resulting in an operating margin of -19.7%.
LFVN - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, LifeVantage Corporation reported an operating income of 1.68M and revenue of 43.72M, resulting in an operating margin of 3.8%.
XGN - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, Exagen Inc. reported a net income of -3.97M and revenue of 17.31M, resulting in a net margin of -22.9%.
LFVN - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, LifeVantage Corporation reported a net income of 1.36M and revenue of 43.72M, resulting in a net margin of 3.1%.
Frequently Asked Questions
XGN and LFVN have a correlation of 0.16, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
LFVN has higher volatility (52.98%) compared to XGN (28.54%). In terms of maximum drawdown, XGN dropped -95.22% vs LFVN's -99.57%.
XGN currently has the higher Sharpe Ratio (-0.56 vs -0.65), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.
Find the right allocation for XGN and LFVN
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer